CHLZT induced expression of p-AMPKα and PPARγ, but inhibited expression of ACC-α, p-ACC-α, SREBP-2, and HMGR in NAFLD cells. Here, SREBF2 is linked to metabolic dysfunction-associated steatotic liver disease.